TScan Therapeutics
TCRX
#9298
Rank
C$95.32 M
Marketcap
$1.68
Share price
-5.56%
Change (1 day)
-83.13%
Change (1 year)

Revenue for TScan Therapeutics (TCRX)

Revenue in 2024 (TTM): C$3.87 Million

According to TScan Therapeutics's latest financial reports the company's current revenue (TTM ) is C$3.98 Million. a decrease over the revenue in the year 2023 that were of C$27.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TScan Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 C$4.04 M-85.53%
2023 C$27.91 M52.01%
2022 C$18.36 M42.11%
2021 C$12.92 M834.19%
2020 C$1.38 M